SCHEMBL20127384

SCHEMBL20127384

c1ccc2cc(-c3ccc4oc5c6ccccc6c(-c6c7ccccc7c(-c7ccc8ccccc8c7)c7ccccc67)cc5c4c3)ccc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 1/20 0.40
CYP1B1 Q16678 1/20 0.40
RAB9A P51151 2/20 0.37
NPC1 O15118 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
KDM4E B2RXH2 4/20 0.37
MAPT P10636 4/20 0.37
ALDH1A1 P00352 3/20 0.37
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
POLB P06746 2/20 0.37
ESR1 P03372 2/20 0.37
HPGD P15428 2/20 0.36
TSHR P16473 2/20 0.36
HSD17B10 Q99714 2/20 0.36
ALOX15 P16050 1/20 0.36
CASP1 P29466 1/20 0.36
CASP7 P55210 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127388 0.96 PGR (0.40) CYP1A1CYP1B1RAB9ANPC1CYP1A2
SCHEMBL20127371 0.93 CYP1A1 (0.41) CYP1A1CYP1B1RAB9ANPC1CYP1A2
SCHEMBL20127436 0.93 ALOX5 (0.42) CYP1A1CYP1B1RAB9ANPC1CYP1A2
SCHEMBL10122449 0.92 ALOX5 (0.43) CYP1A1CYP1B1RAB9ANPC1CYP1A2
SCHEMBL20127375 0.91 KDM4E (0.41) CYP1A1CYP1B1RAB9ANPC1CYP1A2
SCHEMBL10122609 0.90 CYP1A1 (0.41) CYP1A1CYP1B1RAB9ANPC1CYP1A2
SCHEMBL20416956 0.90 ALOX5 (0.40) CYP1A1CYP1B1RAB9ANPC1CYP1A2
SCHEMBL20127387 0.90 ALDH1A1 (0.40) CYP1A1CYP1B1RAB9ANPC1CYP1A2
SCHEMBL20127372 0.90 KDM4E (0.40) CYP1A1CYP1B1RAB9ANPC1CYP1A2
SCHEMBL20127376 0.90 ALOX5 (0.42) CYP1A1CYP1B1RAB9ANPC1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 CYP1A1 399/4885CYP1B1 341/4885RAB9A 2163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.